Keywords: chris, brinsmead, named, abpi, president, designate, anglo-swedish

Chris Brinsmead named as ABPI president designate

Article | 10 December 2007

Print This

Chris Brinsmead, president of Anglo-Swedish drugmaker AstraZeneca in the UK, has been named as president designate of the Association of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in